|
TUBGCP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.00389976518545E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.29549959438214E-10 |
| Normal-vs-Stage2 |
5.955800E-04 |
| Normal-vs-Stage3 |
3.95230514982359E-11 |
| Normal-vs-Stage4 |
6.385700E-04 |
| Stage1-vs-Stage2 |
1.475620E-01 |
| Stage1-vs-Stage3 |
1.328630E-01 |
| Stage1-vs-Stage4 |
2.270600E-01 |
| Stage2-vs-Stage3 |
2.014000E-02 |
| Stage2-vs-Stage4 |
9.158200E-01 |
| Stage3-vs-Stage4 |
3.885700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83379986143473E-10 |
| Normal-vs-AfricanAmerican |
4.232800E-04 |
| Normal-vs-Asian |
8.750400E-02 |
| Caucasian-vs-AfricanAmerican |
2.764400E-01 |
| Caucasian-vs-Asian |
5.008400E-01 |
| AfricanAmerican-vs-Asian |
8.371000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.57640053525199E-10 |
| Normal-vs-Female |
1.50730000036958E-07 |
| Male-vs-Female |
2.377400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.44359999999055E-05 |
| Normal-vs-Age(41-60Yrs) |
7.61369967072767E-10 |
| Normal-vs-Age(61-80Yrs) |
4.03330000509072E-08 |
| Normal-vs-Age(81-100Yrs) |
1.060030E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.546200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.187800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.024400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.523800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.473200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.177000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.846500E-02 |
| Normal-vs-Grade 2 |
6.2992999705358E-09 |
| Normal-vs-Grade 3 |
7.36619654162496E-11 |
| Normal-vs-Grade 4 |
9.58580000000042E-05 |
| Grade 1-vs-Grade 2 |
3.313000E-01 |
| Grade 1-vs-Grade 3 |
2.118400E-01 |
| Grade 1-vs-Grade 4 |
5.717400E-01 |
| Grade 2-vs-Grade 3 |
6.211200E-01 |
| Grade 2-vs-Grade 4 |
6.448800E-01 |
| Grade 3-vs-Grade 4 |
4.476800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.95059995828007E-09 |
| Normal-vs-ccB subtype |
6.45079989425312E-10 |
| ccA subtype-vs-ccB subtype |
2.363200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.31489999999346E-07 |
| Normal-vs-N1 |
7.162400E-03 |
| N0-vs-N1 |
9.837600E-01 |
|
|
